United States Food and Drug Administration (USFDA) has concluded an inspection at Jubilant Pharmova’s wholly owned subsidiary -- Jubilant HollisterStier LLC's (JHS) contract manufacturing facility located in Spokane, WA. U.S.A on June 17, 2026. The USFDA had issued 8 observations, none of which are related to sterility assurance concerns.
JHS will respond to the inspection observations within 15 business days. The company is committed to addressing the observations comprehensively.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.
